Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial-Reference-Cited by-同舟云学术

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

Published:2011-08 Issue:9790 Volume:378 Page:498-506
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Burt Richard K,Shah Sanjiv J,Dill Karin,Grant Thomas,Gheorghiade Mihai,Schroeder James,Craig Robert,Hirano Ikuo,Marshall Karin,Ruderman Eric,Jovanovic Borko,Milanetti Francesca,Jain Sandeep,Boyce Kristin,Morgan Amy,Carr James,Barr Walter

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Autologous hematopoietic stem cell transplantation for systemic sclerosis;Milanetti;Curr Stem Cell Res Ther,2011

2. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study;Farge;Br J Haematol,2002

3. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR registry;Farge;Ann Rheum Dis,2004

4. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis;Oyama;Bone Marrow Transplant,2007

5. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis;Vonk;Ann Rheum Dis,2008

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis;Cell;2024-09

2. Stem-cell therapy in dermatology – Challenges and opportunities;Indian Journal of Skin Allergy;2024-08-05

3. Interdisziplinäre Zentren für Autoimmunerkrankungen in Deutschland;Zeitschrift für Rheumatologie;2024-07-25

4. 2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis;Advances in Rheumatology;2024-07-10

5. Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?;La Revue de Médecine Interne;2024-07